欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号AT/H/1015/002
药品名称Progedex 25 mg Injektionslösung
活性成分
    • Progesterone 25.0 mg/ml
剂型Solution for injection
上市许可持有人IBSA FARMACEUTICI ITALIA S.R.L. VIA MARTIRI DE CEFALONIA 2 LODI I-26900 ITALY
参考成员国 - 产品名称Austria (AT)
Progedex 25 mg Injektionslösung
互认成员国 - 产品名称
    • Belgium (BE)
    • Bulgaria (BG)
      Prolutex
    • Denmark (DK)
    • Estonia (EE)
      LUBION
    • Finland (FI)
    • Lithuania (LT)
      Prolutex 25 mg injekcinis tirpalas
    • Latvia (LV)
      Lubion 25 mg šķīdums injekcijām
    • Norway (NO)
    • Netherlands (NL)
    • Romania (RO)
      Prolutex 25 mg, Solution for injection
    • Sweden (SE)
      Prolutex
    • United Kingdom (Northern Ireland) (XI)
      PL 21039/0026 - 0022
    • Germany (DE)
      Prolutex 25 mg Injektionslösung
    • Luxembourg (LU)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Hungary (HU)
      PROLUTEX 25 mg oldatos injekció
    • Cyprus (CY)
      PROLUTEX 25mg SOL FOR INJ
    • Czechia (CZ)
      Prolutex 25 mg/ml injekční roztok
    • Slovakia (SK)
      Prolutex 25 mg/ml injekčný roztok
许可日期2013/01/23
最近更新日期2025/09/28
药物ATC编码
    • G03DA04 progesterone
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase